cifenline has been researched along with Active Hyperemia in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Coronary hyperemia was induced by an intravenous infusion of adenosine triphosphate and CFVR was calculated as the ratio of hyperemic to basal mean coronary diastolic flow velocity." | 1.33 | Cibenzoline improves coronary flow velocity reserve in patients with hypertrophic obstructive cardiomyopathy. ( Daimon, M; Hasegawa, R; Kawata, T; Komuro, I; Sekine, T; Takazawa, K; Takei, Y; Tanaka, N; Teramoto, K; Yoshida, K, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sekine, T | 1 |
| Daimon, M | 1 |
| Hasegawa, R | 1 |
| Teramoto, K | 1 |
| Kawata, T | 1 |
| Tanaka, N | 1 |
| Takei, Y | 1 |
| Takazawa, K | 1 |
| Yoshida, K | 1 |
| Komuro, I | 1 |
1 other study available for cifenline and Active Hyperemia
| Article | Year |
|---|---|
Cibenzoline improves coronary flow velocity reserve in patients with hypertrophic obstructive cardiomyopathy.
Topics: Adenosine Triphosphate; Aged; Analysis of Variance; Anti-Arrhythmia Agents; Blood Flow Velocity; Car | 2006 |